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Abstract
Context—The Centers for Disease Control and Prevention evaluated the economics of the 
National Program of Cancer Registries to provide the Centers for Disease Control and Prevention, 
the registries, and policy makers with the economic evidence-base to make optimal decisions 
about resource allocation. Cancer registry budgets are under increasing threat, and, therefore, 
systematic assessment of the cost will identify approaches to improve the efficiencies of this vital 
data collection operation and also justify the funding required to sustain registry operations.
Objectives—To estimate the cost of cancer registry operations and to assess the factors affecting 
the cost per case reported by National Program of Cancer Registries–funded central cancer 
registries.
Methods—We developed a Web-based cost assessment tool to collect 3 years of data 
(2009-2011) from each National Program of Cancer Registries–funded registry for all actual 
expenditures for registry activities (including those funded by other sources) and factors affecting 
registry operations. We used a random-effects regression model to estimate the impact of various 
factors on cost per cancer case reported.
Results—The cost of reporting a cancer case varied across the registries. Central cancer 
registries that receive high-quality data from reporting sources (as measured by the percentage of 
records passing automatic edits) and electronic data submissions, and those that collect and report 
on a large volume of cases had significantly lower cost per case. The volume of cases reported had 
a large effect, with low-volume registries experiencing much higher cost per case than medium- or 
high-volume registries.
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Conclusions—Our results suggest that registries operate with substantial fixed or semivariable 
costs. Therefore, sharing fixed costs among low-volume contiguous state registries, whenever 
possible, and centralization of certain processes can result in economies of scale. Approaches to 
improve quality of data submitted and increasing electronic reporting can also reduce cost.
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Cancer is the second leading cause of death among people in the United States, responsible 
for approximately 1 in 4 deaths.1 During 2011, more than 1.5 million people in the United 
States were diagnosed with cancer, and more than half a million died of their cancers.2 
Cancer accounts for approximately 5% of overall national health care expenditures.3,4 
Information from cancer registries is used to track cancer trends; assess cancer disparities; 
assess progress toward cancer prevention and control objectives, including those established 
by Healthy People 2020; and identify additional needs for cancer prevention and control 
efforts at national, state, and local levels (http://www.cdc.gov/cancer/npcr/about.htm/).
The National Program of Cancer Registries (NPCR) (http://www.cdc.gov/cancer/npcr/
about.htm) is administered by the Centers for Disease Control and Prevention (CDC) and 
provides financial and technical support for the operation of central population-based cancer 
registries. Currently, the NCPR funds 45 states, the District of Columbia, Puerto Rico, and 
the Pacific Island Jurisdictions. Cancer registries in some states and metropolitan areas are 
also funded by the National Cancer Institute's Surveillance, Epidemiology, and End Results 
(SEER) program (http://seer.cancer.gov/registries/). Together, the NPCR and the SEER 
collect data for the entire US population.
Although NPCR has been funded by Congress since 1994, no comprehensive study of the 
economic costs incurred by the NPCR has been conducted. A previous study used federal 
funding sources to estimate the average cost per case reported by NPCR-funded registries 
and to identify factors that explain state variations.5 This study underestimated the true costs 
because other sources of funding were not included, such as state government funds, and in-
kind contributions.6-8 Understanding the true cost of cancer registration is essential to 
forecast funding requirements, identify resources required to enhance data collection 
activities, and also to assess efficiencies in data collection approaches. It is also important to 
systematically quantify the resources required to ensure that high-quality cancer registry 
data are collected and reported.
The objective of the current study is to estimate the cost of reporting a cancer case by the 
NPCR-funded registries and to assess the factors affecting the cost per case reported. Prior 
studies have shown that there are potentially large variations in cost per case among 
registries.6-8 Central cancer registries are complex and perform many activities, including 
those related to core surveillance (ie, activities related to data collection and development of 
the registry database) and advanced activities (such as active follow-up and implementing 
cancer inquiry response systems to improve quality and completeness of the registry data). 
Cancer registry budgets are under increasing threat, and, therefore, systematic assessment of 
the cost will identify approaches to improve the efficiencies of this vital data collection 
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operation and also justify the funding required to sustain registry operations to report high-
quality data.
Methods
We collected 3 years (fiscal years 2009-2011) of data on funding, cost of operations 
(including in-kind contributions), and factors that affect the efficiency of operating central 
cancer registries. Three years of data were collected to allow for a more precise analysis of 
registry costs and cost per case reported, as well as the sample size necessary to conduct the 
regression-based analysis presented in this study. The nature of registry operations may 
result in significant variation in registry activities and, therefore, costs from year to year. In 
addition, because case reporting may be delayed and data collection for a given case 
continues over many years, the number of cases reported in any given reporting period may 
not result in accurate assessments; longer study time periods should result in better 
estimation.8
Cost data collection
A Web-based Cost Assessment Tool was developed to collect activity-based cost data from 
the 48 NPCR-funded registries.7,9-11 Details on the development of the tool and the pilot-
testing process have been previously reported.7 Cost data were collected across the 
following budget categories: labor, consultant and contract expenditures, computer software 
and hardware, travel and training, and administrative or overhead expenses.
The programmatic perspective was used for the analysis, and, therefore, all funding and 
costs relevant to the program operations were collected. Registries reported funding from 3 
types of sources: NPCR funds, other federal funds, and nonfederal funds. Registries 
provided data about actual (rather than budgeted) cost incurred and information on all in-
kind labor and non-labor contributions. Registry staff members were asked to allocate cost 
and employee time to standardized registry activities. In-house labor (registry staff) is the 
largest cost incurred by cancer registries, and, therefore, in-depth assessment of staff time 
spent on activities was undertaken to ensure accurate generation of activity-based costs. In 
addition, staff compensation was collected using specific detailed categories to ensure all 
costs related to salary and fringe benefits were captured.
In general, information technology and equipment (eg, computers and office furniture) were 
covered through the indirect or overhead cost contributions. Many of the registries also used 
software provided by the CDC, which is available free of charge. Registry operations are 
complex, and on the basis of preliminary review, we determined that it would not be possible 
to accurately determine fixed, semifixed, and variable components and, therefore, we did not 
classify costs into these categories. No information on resources expended by hospitals and 
other reporting sources to provide data to cancer registries is included in this analysis, as this 
study uses a programmatic (cancer registry program) perspective. To ensure that data were 
consistently reported across the registries, registry staff were offered the following: webinar-
based training, a user's guide with detailed definitions of each core and advanced activity, 
and ongoing technical assistance to address any questions about data collection and 
reporting.
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Incidence cases studied
National Program of Cancer Registries–funded registries report all invasive cancers 
diagnosed among residents of their state on an annual basis to the CDC. In addition to these 
reporting requirements, many registries collect additional cases. These may include cases 
reported by SEER registries, cases reported for research purposes, and cases diagnosed in 
other states. Out-of-state incidence cases may be shared with the appropriate registry 
through case-sharing agreements. To standardize cost per case calculations, we limited the 
cases reported to in-state cases collected by the registry.
Calculating cost per case of cancer reported
Following data validation, we derived activity-based cost estimates for each registry. First, 
we allocated costs to specific registry activities by summing the cost of each registry activity 
across all budget categories (eg, personnel costs were allocated across activities on the basis 
of the reported percentage time spent on each activity). Next, we added together 
expenditures that did not have any associated registry activity and prorated those costs across 
all registry activities. Then, we calculated cost per case, both overall and by registry activity. 
Finally, we classified the cost into core and advanced activities. Cost per case values were 
adjusted to 2011 dollars to account for regional cost of living differences by using the 
Employment Cost Index.12
Factors affecting cost per case
Region, representing population size and geographic area, is one characteristic that may 
affect the cost of registry operations beyond variations in costs across regions. CDC uses the 
US Census regions (Northeast, South, Midwest, or West) for each registry, with the 
exception of Puerto Rico and the Pacific Island Jurisdictions which are not part of any 
census region or census division.13 The number of cases collected or the time required to 
collect data from dispersed data sources may affect the cost of collecting cancer incidence 
data. We identified population size as low (below 2.8 million people), medium (2.8-6 million 
people), or high (>6 million people) on the basis of the US Census Bureau population 
estimates for 2011, and we classified geographic area as small (<42 000 square miles), 
medium (42 000-69 000 square miles), or large (>69 000 square miles).
Case volume and consolidation effort are both likely to drive cost per case. Case volume is 
the number of incidence cases diagnosed during a given year and collected by the registry. 
We classified case volume as low (<10 000 cases), medium (10 000-50 000 cases), and high 
(>50 000 cases). These cut points were determined by review of the data; medium volume 
represents most of the registries, with low and high volume identifying outliers. The map in 
Figure 1 illustrates the volume of incidence cases reported (case volume).
We calculate consolidation effort, which is a routine activity performed by all registries, by 
dividing the number of cases reported by the number of records received and then 
subtracting that ratio from 1. A single incidence case may have several records attached to it, 
requiring consolidation to eliminate duplicate records and retention of additional 
information. Consolidating many records to fewer cases will require more effort and, 
therefore, may affect registry efficiency.
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Other characteristics that may potentially affect registry efficiency include the following: the 
portion of cases from reporting sources that pass automatic edits; whether a registry has a 
major contractor who carries out all or a significant portion of the registry's operations; the 
portion of records that the registry receives via electronic submissions; and North American 
Association of Central Cancer Registries (NAACCR) Certification status (http://
www.naaccr.org/Certification/CertificationLevels.aspx). Automatic edits and electronic 
submissions could require less effort for case reporting, resulting in a lower cost per case as 
the percentage of records or cases meeting these criteria increase. NAACCR Certification is 
awarded on the basis of the completeness, accuracy, and timeliness of the data submitted by 
registries and, therefore, an important measure of the quality achieved by the registries. Gold 
or silver status may reflect other unmeasurable registry characteristics that could affect 
efficiency of registry operations.
Program exclusion criteria
On the basis of consultations with registry experts and preliminary data analysis, we 
excluded SEER registries (fully or partially funded) from this analysis. Because we are 
analyzing registry-level data, we excluded these observations from our regression model to 
avoid unmeasured differences between these registries and the other NPCR registries. 
Surveillance, Epidemiology, and End Results registries are required to collect and report 
more detailed information than NPCR registries; this fundamental difference in registry 
operations cannot be adequately addressed, nor controlled for in multivariate analysis. In 
addition, we also excluded the Pacific Regional Central Cancer Registry as CDC awarded 
the first cooperative agreement only in 2007, and this registry was not fully operational 
during the data collection period.
Multivariable regression specification
Multivariate analysis was used to assess the factors affecting the cost per case reported by 
NPCR-funded central cancer registries. We have used the log transformation of the 
dependent variable, cost per case, to account for the skewness in the distribution of the cost 
across the registries. We estimated the following equation by using a random-effects model:
where Y is a dependent variable (ie, log of total cost per case reported); X is a vector of 
registry characteristics; R is a vector of other factors that may affect registry operations; u is 
the between-entity error term; and ε is the within-entity error term.
Random-effects models allow for estimation of time-invariant variables given that certain 
registry characteristics do not vary across the 3 years of panel data used in this analysis. We 
performed a Hausman test to confirm that a random-effects model is appropriate for our 
analyses.14 Registry characteristics include geographic area, region, population size, case 
volume, and case consolidation effort. Other factors included in our regression analysis are 
the percentage of cases received that pass 100% edits and the percentage of records that are 
submitted electronically. We generated correlation coefficients for all potential variables to 
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avoid multi-collinearity. We used a forced-in stepwise regression approach when developing 
the model to determine those factors that had a clear effect on cost per case. Although the 
summary statistics presented below (see discussion of Table 1) include additional variables, 
the regression model includes only the variables noted previously. All regression analyses 
and statistical tests of the model were performed by using the Stata statistical package, 
version 12.0.14
Results
Table 1 presents data about several registry characteristics and other factors, including those 
controlled for in our regression analyses. The largest proportion of the 40 registries included 
in our analyses were located in the South. Population size and geographic area were fairly 
evenly distributed. Half of the registries in our sample were programs with medium case 
volume. The majority of registries also reported medium consolidation effort. Twenty 
percent of registries had a major contractor who carried out all or a significant portion of the 
registry's operations. Many of the registries achieved NAACCR gold or silver status in 2011.
Table 2 presents average registry funding and the source of the funding for each reporting 
year for the 40 study registries. On average, nearly 61% of total registry funding came from 
NPCR. Nearly 39% of registry funding was from nonfederal sources, whereas less than 1% 
of registry funds came from other federal sources. The average amount of total funding for 
each central cancer registry was $1 154 474. Of this amount, $700 998 were NPCR funds, 
$9021 were other federal funds, and $444 455 were nonfederal funds. Table 2 also presents 
the distribution of registry expenditures and the cost per case of core and advanced activities 
for each reporting period and averaged across the 3 years. The majority of registry funds, 
approximately 93%, were spent on core registry activities. The average cost per case across 
3 years of data collected was $60.77 for all activities; $56.52 for core registry activities, and 
was $4.25 for advanced registry activities.
Table 3 presents the random-effects estimates of regionally adjusted cost per case by using a 
longitudinal (panel) data set containing 3 years of data for 40 NPCR registries. Note that 
cost per case is measured in logs to adjust for skewness in the variable. Higher case volume 
results in significantly lower cost per case, although there is little additional cost reduction 
for high volume relative to medium case volume (66% vs 54% lower for high and medium 
volume, respectively, compared to low volume). Even after adjusting for regional differences 
in employment costs, registries in the Midwest and West have a lower cost per case relative 
to registries in the South (73% and 30% lower per case, respectively). High consolidation 
effort (relative to low effort) increases cost per case (32%). As the percentage of records 
passing all automatic edits increases, cost per case decreases. The same holds true for the 
percent of records submitted electronically.
Figure 2 presents the unadjusted distribution of cost per case-by-case volume for all 3 years 
of data. As case volume increased, cost per case reported tended to decrease as revealed in 
the multivariate analysis presented in Table 3. The shape of the potential curve connecting 
the points on the graph is an inverse exponential distribution. There is a wide distribution in 
cost per case among low-volume registries, those under 10 000 cases, ranging from $40 per 
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case to $310 per case. Larger registries, those that report more than 30 000 cases, all 
consistently have cost per case of about $50 or lower. Although registries with the highest 
volume seem to report costs close to $50 per case, there is no systematic evidence indicating 
diseconomies of scale given the current volume of distribution of cancer case registrations.
Discussion
We analyzed 3 years of cost data reported by 40 central cancer registries funded by the 
NPCR. We saw little variation in the proportion of funding from different funding sources 
and in the average distribution of expenditures between core and advanced registry activities 
across the 3 years of data. The average cost per cancer case reported was about $61, but 
there was variation across registries. Receipt of high-quality data (as measured by the 
percentage of records passing automated edits), electronic reporting, and processing large 
volume of cases all result in significantly lower cost per case. We also identified some 
regional variation, with registries in the Midwest and West reporting lower costs on average.
The volume of cases reported has a large effect, indicating that there are economies of scale 
to be achieved as the cost per case significantly decreases with larger volume of cancer cases 
reported. This also indicates that there are potentially substantially fixed or semivariable 
costs associated with registry activities. These fixed costs can relate to facilities and other 
infrastructure required for data processing and reporting. Therefore, sharing of fixed costs 
among small volume contiguous state registries, whenever possible, and centralization of 
certain processes, may help reduce the overall average cost of cancer registration. Some state 
laws preclude the sharing of identifiable cancer registry data, but registries can develop 
innovative processes to consolidate efforts and still comply with state policies.
In addition, there is not a large difference in cost per case between medium- and high-
volume registries, which leads to the conclusion that once registries reach a certain size 
(about 30 000 cases), there is not much additional economies of scale to be gained. There 
was large variation in the unadjusted cost per case among low-volume registries, which 
could indicate that there may be additional lessons to be learned by reviewing low-volume 
registries that may be efficient or may receive better-quality data that allows them to incur 
lower costs. We plan to explore the reasons for this variation in cost among low-volume 
registries in the next series of analyses planned for the economic evaluation of the NPCR 
registries.
The present research updates the prior work on assessing variation in cost across NPCR-
funded cancer registries.5 We used more recent years of data and a more in-depth approach 
to collect activity-based costs, which focused on assessing all costs regardless of funding 
source. The prior research5 concluded that cost per case was inversely affected by volume of 
cancer cases reported, and that size of area served by the registry was positively associated 
with higher cost. In the present study, area served was not statistically significant, which 
could reflect shifts in data abstraction and reporting from a more manual process to a larger 
role of electronic reporting.6 In our sample, about 80% of the registries received a majority 
of their records electronically, indicating widespread use of electronic reporting. The process 
of moving away from manual abstraction could substantially decrease travel and staff time, 
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and this could be the reason for the lack of significance of area served in this updated 
analysis.
Our results indicate that although a key driver of cost per case is case volume, registries 
receiving high-quality data also have significantly lower cost per case. As health care 
providers move increasingly toward electronic medical records and an automated process of 
reporting cancer incidence, there is opportunity for the quality of data received by the cancer 
registries to improve (only half the registries receive cases that pass 100% of electronic edits 
currently), and this could result in further efficiencies. Electronic reporting of cancer cases 
will increase in the near future, as it is a specific public health objective for Stage 2 
Meaningful Use.15 Having a wide range of health care providers reporting to cancer 
registries should address current underreporting of certain cancers, such as melanoma and 
prostate cancer, which may be diagnosed and treated in physician's offices, and potentially 
reduce the work by cancer registry staff who collect and manage the data.
A potential limitation of the data analysis presented in this study is that the registries report 
data retrospectively, and the potential for recall error makes the reliability of retrospective 
data uncertain. A second limitation is the geographic diversity of the registries. The cost data 
were adjusted to account for regional variation, and we also included the 4 regions as 
additional control variables in the multivariable regression analysis. Differences between 
registries may persist despite these attempts to adjust for potential cost of living variations. 
A third limitation is reporting information about cancer cases, which involves data collection 
for each case that spans over several years. Therefore, although we used 3 years of data, 
there may still be a mismatch in aligning registry cost to the specific cases reported because 
of a lag in the reporting of cancer cases.8 A longer time period may be required to estimate 
the true cost of cancer registration. Fourth, additional approaches to assess quality of the 
data may be needed as there is little variation in the core measures used to assess quality of 
cancer registry data currently. Finally, although we were able to include all established 
registries funded by the NPCR, the overall sample size of the panel data of 40 registries and 
3 years of data may not be large enough to capture all the potential differences between the 
registries.
This study's findings about the cost of operating cancer registries and factors that affect cost 
provide CDC and the registries with opportunities to identify cost savings and efficiency 
improvements. Additional processes to improve the quality of the data submitted to the 
cancer registries may improve efficiency, and the projected increase in electronic reporting 
of cancer incidence offers a unique opportunity to address data quality and efficiency. 
Furthermore, some consolidation and centralization of data collection and reporting 
processes, particularly among small-volume registries, may reduce the potential high fixed 
costs faced by cancer registries and decrease the overall cost of reporting a cancer case. 
Achieving efficiencies in cancer registry data collection is essential to ensure that high-
quality data are available to guide the selection and implementation of future cancer 
prevention and control interventions.
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Figure 1. Map of US Cancer Registries With Volume of Incident Cancer Cases Recorded by 
Cancer Registries by Statea
Abbreviation: NPCR, National Program of Cancer Registries. aOur analysis excludes Pacific 
Island Jurisdictions. The registry did not report cases diagnosed in 2006 and is still ramping 
up case reporting. Low case volume distorts cost per case calculations. We also exclude 
SEER (Connecticut, Hawaii, Iowa, New Mexico, and Utah), NPCR-SEER (Kentucky, 
Louisiana, New Jersey), NPCR states with SEER metro areas (Georgia, Michigan, and 
Washington), and NPCR states with SEER metro and regional coverage (California) from 
this study. Shading denotes case volume (low, medium, and high). Patterns denote federal 
funding sources in place at the time this study began (2009).
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Figure 2. 
Cost Per Case by Volume of Incident Cancer Cases Reported by Cancer Registries, National 
Program of Cancer Registries (Years 2009, 2010, and 2011)
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Table 1
Cancer Registry Characteristics, National Program of Cancer Registries
NPCR Registries (n = 40)a,b
Case volume
 Low (<10 000 cases) 32.5%
 Medium (10 000-50 000 cases) 50.8%
 High (>50 000 cases) 16.7%
Consolidation effort
 Low (<22%) 28.3%
 Medium (22%-33%) 44.2%
 High (>33%) 27.5%
Region
 Northeast 16.7%
 South 38.3%
 Midwest 25.0%
 West 20.0%
Geographic area
 Small (<42 000 square miles) 36.7%
 Medium (42 000-69 000 square miles) 30.8%
 Large (>69 000 square miles) 32.5%
Population
 Low (<2.8 million) 37.5%
 Medium (2.8-6 million) 35.4%
 High (>6 million) 27.1%
Other characteristics
 Cases passing 100% edits 52.8%
 Records submitted electronically 80.6%
 Major contractor 20.0%
 NAACCR gold status (2011) 77.5%
 NAACCR silver status (2011) 7.5%
Abbreviations: NAACCR, North American Association of Central Cancer Registries; NPCR, National Program of Cancer Registries.
a
Excludes the Pacific Regional Central Cancer Registry. Registry did not report cases diagnosed in 2006 and is still ramping up case reporting. Low 
case volume distorts cost per case calculations.
b
Excludes NPCR registries that also receive SEER funding: California (San Francisco-Oakland, San Jose-Monterey, Los Angeles), Georgia 
(Atlanta), Kentucky, Louisiana, Michigan (Detroit), New Jersey, and Washington (Seattle-Puget Sound).
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Table 2
Funding by Source and Distribution of Expenditure on Core and Advanced Registry 
Activities by Fiscal Year, National Program of Cancer Registries
NPCR Registries (n =40)a,b
2009 2010 2011 Average
Funding amount ($)
 Total funding received 1 147 004 1 149 302 1 167 118 1 154 475
Share of funding (%)
 NPCR 59.56% 60.34% 62.23% 60.71%
 Other federal funds 1.17% 0.70% 0.48% 0.78%
 Nonfederal funds 39.27% 38.96% 37.29% 38.51%
Registry activities (%)
 Core 93.41% 92.57% 93.07% 93.01%
 Advanced 6.59% 7.43% 6.93% 6.99%
Cost per case ($)
 Core $54.19 $57.08 $58.30 $56.52
 Advanced $3.82 $4.58 $4.34 $4.25
 All activities (total) $58.01 $61.66 $62.64 $60.77
Abbreviation:NPCR, National Program of Cancer Registries.
a
Excludes the Pacific Regional Central Cancer Registry. Registry did not report cases diagnosed in 2006 and is still ramping up case reporting. Low 
case volume distorts cost per case calculations.
b
Excludes NPCR registries that also receive Surveillance, Epidemiology, and End Results funding: California (San Francisco-Oakland, San Jose-
Monterey, Los Angeles), Georgia (Atlanta), Kentucky, Louisiana, Michigan (Detroit), New Jersey, and Washington (Seattle-Puget Sound).
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Table 3
Cost per Incident Cancer Case Reported, Adjusted for Regional Cost of Living, National 
Program of Cancer Registries
Dependent Variable Cost per Case—All Activitiesa,b,c
Independent Variablesd (Comparator in Italics) 95% Confidence Interval
Estimate Lower Higher
Case volume (reference: low) …
 Medium case volume
−0.782e −0.853 −0.711
 High case volume
−1.073e −1.202 −0.944
Consolidation effort (reference: low) …
 Medium consolidation effort −0.029 −0.161 0.220
 High consolidation effort 0.275f 0.019 0.531
Region (reference: South) …
 Northeast −0.086 −0.309 0.137
 Midwest
−0.552e −0.656 −0.449
 West
−0.357e −0.444 −0.271
Geographic area (reference: small) …
 Medium geographic area 0.020 −0.087 0.126
 Large geographic area 0.366e 0.189 0.542
 % of records passing 100% edits
−0.098e −0.105 −0.092
 % of records submitted electronically
−0.493e −0.773 −0.213
Constant 4.963
Number of observations 120.00
Abbreviation: NPCR, National Program of Cancer Registries.
a
Excludes the Pacific Regional Central Cancer Registry. Registry did not report cases diagnosed in 2006 and is still ramping up case reporting. Low 
case volume distorts cost per case calculations.
b
Excludes NPCR registries that also receive Surveillance, Epidemiology, and End Results funding: California (San Francisco-Oakland, San Jose-
Monterey, Los Angeles), Georgia (Atlanta), Kentucky, Louisiana, Michigan (Detroit), New Jersey, and Washington (Seattle-Puget Sound).
cCost per case adjusted using area wage index as noted in text previously. Log values are used.
d
Final model presented previously. R2 was 0.60 for this model. The following variables were dropped from the specification because of limited 
explanatory power or correlation between regressors: population size flags (low, medium, high); contractor flag; and North American Association 
of Central Cancer Registries status (gold or silver).
e
.001%; robust standard errors.
f
.05%; robust standard errors.
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